Verified Nov 2026
Batteries & E-Mobility
·

San Diego, California
·
Since
Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, California, with 500–1,000 employees and estimated revenue of $100–250 million. The company develops small-molecule anti-inflammatory and anti-fibrotic therapies for organ fibrosis and inflammatory diseases, serving the automotive, electric-vehicle, and medical sectors. It completed an acquisition of Cullgen in May 2026 to establish an integrated biopharmaceutical operation spanning the United States and China.
Gyre Therapeutics at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Headquarters
San Diego, California
Industries
Automotive
Electric Vehicles
Medical
Overview
Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, California, with 500–1,000 employees and estimated revenue of $100–250 million. The company develops small-molecule anti-inflammatory and anti-fibrotic therapies for organ fibrosis and inflammatory diseases, serving the automotive, electric-vehicle, and medical sectors. It completed an acquisition of Cullgen in May 2026 to establish an integrated biopharmaceutical operation spanning the United States and China.
At a glance
Attribute | Detail |
|---|---|
Headquarters | San Diego, California |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
Primary capability | Batteries & E-Mobility |
What Gyre Therapeutics makes
Gyre's pipeline includes Hydronidone, a small-molecule candidate for liver fibrosis, and ETUARY®, an approved treatment for Idiopathic Pulmonary Fibrosis marketed in China.
Latest developments
2026-11-05 — Gyre Therapeutics Reports Third Quarter 2026 and Year-to-Date Financial Results with Business Updates | Gyre Therapeutics, Inc (gyretx.com)
2026-08-07 — Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update | Gyre Therapeutics, Inc (gyretx.com)
2026-05-12 — Press Releases | Gyre Therapeutics, Inc (gyretx.com)
2026-05-07 — Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update | Gyre Therapeutics, Inc (gyretx.com)
2026-05-04 — Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company | Gyre Therapeutics, Inc (gyretx.com)
2026-03-02 — Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline | Gyre Therapeutics, Inc (gyretx.com)
Facilities
Gyre Therapeutics is headquartered in San Diego, California. Public sources also reference these locations:
China — gyretx.com
Company details
The company went public on Nasdaq under the ticker GYRE on October 31, 2023, and maintains a controlling interest in Beijing Continent Pharmaceuticals. Gyre Therapeutics has an estimated 500-1,000 employees, and is headquartered in San Diego, California.
Frequently asked questions
What does Gyre Therapeutics make?
Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, California, with 500–1,000 employees and estimated revenue of $100–250 million. The company develops small-molecule anti-inflammatory and anti-fibrotic therapies for organ fibrosis and inflammatory diseases, serving the automotive, electric-vehicle, and medical sectors. It completed an acquisition of Cullgen in May 2026 to establish an integrated biopharmaceutical operation spanning the United States and China.
Where is Gyre Therapeutics headquartered?
Gyre Therapeutics is headquartered in San Diego, California (12770 High Bluff Dr, San Diego, California, 92130-2057).
How big is Gyre Therapeutics?
Gyre Therapeutics has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
